Courtney Carson manages congressional outreach, policy development, and legislative analysis to support the US advocacy work of the coalition. In this capacity, she serves as GHTC’s primary interface with Congress and helps develop strategies to advance the coalition’s legislative priorities.
Courtney has a background in foreign policy and global health, serving as staff to Senator Chris Coons (D-DE) and managing his chairmanship of the Senate Caucus on Malaria and Neglected Tropical Diseases. Prior to joining GHTC, she managed outreach and policy development for a cross-sector coalition advancing international development, global health, and trade policy. She has also worked to enhance public-private partnerships for international development with ACDI/VOCA and the Corporate Council on Africa.
Courtney received her MA in International Economics and International Relations from the Johns Hopkins School of International Studies and her BA in International Relations, Economics, and French from the University of Delaware. In her free time, she likes to experiment with new recipes and plan her next travel adventure.
At his nomination hearings, Secretary of Health and Human Services-designee Tom Price addressed global health and infectious diseases; innovation for rare diseases; support for health innovation, NIH, and priority setting for NIH-funded research. GHTC covers what he had to say.
As all eyes look toward President-elect Donald Trump's inauguration, GHTC examines the policy issues we'll be tracking on in 2017.
At his nomination hearing, Secretary of State–designee Rex Tillerson was questioned on women’s empowerment, family planning, development aid, and the President’s Emergency Plan for AIDS Relief (PEPFAR). GHTC covers what he had to say.
The Administration announced that it will transfer nearly $600 million in remaining Ebola funds to fight the growing threat of Zika virus. But many questions remain. Where is the money going? What accounts is it coming from? And what does this mean for the Global Health Security Agenda?
On Monday, President Obama released his proposed budget for fiscal year 2017 (FY17).
In November 2015, United Nations (UN) Secretary-General Ban Ki-moon convened a High-Level Panel on Access to Medicines to discuss and develop solutions to promote innovation and access to essential medicines, vaccines, diagnostics, and other health technologies needed to ensure health and well-being around the world.
GHTC has long championed US leadership in global health and innovation, and we were encouraged to see President Barack Obama highlight these themes in his State of the Union address.
Last month, Representatives Albio Sires (D-NJ) and Mario Diaz-Balart (R-FL) introduced a new piece of legislation—the Global Health Innovation Act (H.R. 2241)—that would strengthen global health research and development (R&D) programming at the US Agency for International Development (USAID).
After ten years of debate, on November 5, 2015, international negotiators released the final text of the largest regional trade agreement in history—the Trans Pacific Partnership (TPP).
Update: The Global Health Technologies Coalition is excited to announce that the Global Health Innovation Act (H.R. 2241) passed the House of Representatives on December 18.